Lægemidlet bør kun anvendes til ammende kvinder, hvis den ansvarlige læge skønner, at fordelene herved mere end opvejer risiciene.
The medicinal product should be used in breast-feeding women only when the attending physician decides that the benefits outweigh the risks.